Karl William Salatka, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 638 Fourth Ave, New Kensington, PA 15068 Phone: 724-339-2229 Fax: 724-339-7733 |
News Archive
Chiron Corporation has announced that it has granted a non-exclusive license to the Blood Transfusion Centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and hepatitis C virus (HCV) technology for use in molecular probe "home brew" blood screening.
Measuring a set of proteins in the blood may enable earlier diagnosis of autism spectrum disorder (ASD), according to a study from the Peter O'Donnell Jr. Brain Institute at UT Southwestern Medical Center.
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today the Company has received approval from the United States Food and Drug Administration (FDA) to commence patient screening of a Phase 2b study of PRO 140, a monoclonal CCR5 antibody, for the treatment of patients with Human Immunodeficiency Virus Type 1.
The pacifier was recently tested at Health Canada's Product Safety Laboratory and failed to meet Canadian safety requirements. The nipple from several of the pacifiers detached during testing, and the handle also detached. Young children and babies using the pacifier could choke on or aspirate a piece of it.
› Verified 4 days ago